INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/05/2024
Back to search
Official data from USPTO
MÖLLER ALLEGRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MÖLLER ALLEGRA
ST13
US500000079104886Class
10
Filing
79104886
Registration
4228390
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/05/2024
Trademark type
Word
Nice classes
10
Filing date
09/02/2011
Registration date
10/23/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2023
Last transaction
05/05/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
EINSTEIN, MATTHEW T
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Möller-Wedel Beteiligungen GmbH
Haag-Streit Surgical GmbH & Co. KG
MÖLLER-WEDEL GmbH
Representatives
Rose Auslander Carter Ledyard & Milburn LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Operating microscopes
Publications
History of USPTO decisions and trademark events.
44 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/17/2024
INPC
INVALIDATION PROCESSED
01/17/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/05/2024
C71T
CANCELLED SECTION 71
05/05/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/02/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/23/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/17/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/11/2020
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/10/2019
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
02/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/06/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
01/14/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/23/2017
DCPN
CHANGE OF OWNER RECEIVED FROM IB
11/19/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/11/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2014
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/25/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2013
FIMP
FINAL DISPOSITION PROCESSED
05/04/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/23/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
10/23/2012
GPNX
NOTIFICATION PROCESSED BY IB
09/09/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/07/2012
PUBO
PUBLISHED FOR OPPOSITION
08/07/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/18/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/18/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/18/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/29/2012
ALIE
ASSIGNED TO LIE
06/28/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2012
DOCK
ASSIGNED TO EXAMINER
06/11/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2012
RFNT
REFUSAL PROCESSED BY IB
01/09/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/22/2011
RFRR
REFUSAL PROCESSED BY MPU
12/22/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/22/2011
CNRT
NON-FINAL ACTION WRITTEN
12/21/2011
DOCK
ASSIGNED TO EXAMINER
12/21/2011
MAFR
APPLICATION FILING RECEIPT MAILED
11/29/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/24/2011
Continuous trademark protection
Get notified about every new filing that threatens MÖLLER ALLEGRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.